CTEV · Claritev Corp · Metrics
$18.28
-0.75 (-3.94%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$312.13M
Shares
17.07M
Volume · Nov 20
246.97K
Avg daily vol (3M)
210.86K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
CTEV metrics
91 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$18.28
Market cap
$312.13M
Price action
23 metricsPrice change (1W)
-31.8%
Price change (30D)
-22.2%
Price change (3M)
-51.0%
Price change (6M)
-15.6%
Price change (YTD)
-57.2%
Price change (1Y)
-59.6%
Trailing year
Price change (5Y)
—
52-week high
$54.87
52-week low
$13.47
Change from 52-week high
-66.7%
Change from 52-week low
+35.7%
Annualized volatility
117.2%
Annualized volatility (3M)
88.7%
Implied volatility (30D)
105.5%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
2.3
RSI (14D)
34.4
Price vs SMA 50
-25.8%
Price vs SMA 200
-27.8%
Avg volume (3M)
210,863
Relative volume
1.2
Average dollar volume
$5.55M
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
17.07M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
4.9×
reciprocal yield 20.5%
EV / EBITDA
10.1×
reciprocal yield 9.9%
EV / EBIT
115.0×
reciprocal yield 0.9%
P / sales
0.3×
reciprocal yield 325.8%
P / book
—
FCF yield
-8.9%
TTM · current market cap
Buyback yield
1.1%
P / FCF
—
P / operating cash flow
2.4
reciprocal yield 42.1%
Earnings yield
-88.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
5.3×
reciprocal yield 19.0%
EV / revenue historical average (5Y)
5.5×
reciprocal yield 18.3%
EV / EBIT historical average (3Y)
134.5×
reciprocal yield 0.7%
EV / EBIT historical average (5Y)
82.6×
reciprocal yield 1.2%
EV / EBITDA historical average (3Y)
27.9×
reciprocal yield 3.6%
EV / EBITDA historical average (5Y)
28.2×
reciprocal yield 3.5%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-11-09
Profitability
9 metricsGross margin
—
Operating margin
4.2%
Trailing 12 months
Net margin
-27.1%
Gross profit (TTM)
—
Operating profit (TTM)
$43.05M
Net income (TTM)
−$275.14M
Trailing 12 months
Diluted EPS (TTM)
$-16.42
FCF margin
-2.7%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+9.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.02B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.0%
Year over year · more shares
Revenue CAGR (3Y)
-3.7%
Revenue CAGR (5Y)
+0.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-5.9%
Debt / equity
—
Current ratio
1.2
EBITDA (TTM)
$488.06M
Free cash flow (TTM)
−$27.82M
Quick ratio
1.2
Interest coverage
0.1
Net debt / EBITDA
9.5
Return on invested capital
—
Trailing 12 months
Net cash
−$4.64B
Latest balance sheet
Cash & equivalents
$10.14M
Total assets
$4.68B
Total debt
$4.65B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$131.31M
Capital expenditures (TTM)
$159.13M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$29.27M
R&D / revenue
—
Stock compensation / revenue
2.9%
Ownership (13F)
9 metrics13F filers
106
13F filer change QoQ
+5
Institutional ownership
88.8%
Conviction holders (share of 13F filers)
5.7%
Crowding (high-turnover and private-fund holders)
32.8%
Private-fund adviser ownership
32.6%
Active holders' share change QoQ
+12.2%
Holder tenure
7.1
Price vs estimated holder cost
-27.9%
Ownership (registered funds)
1 metricsIndex-fund ownership
8.3%
Short interest
3 metricsShort interest
4.5%
Latest settlement · 2.9 days to cover
Days to cover
2.9d
Short-squeeze score
44 / 100
Insider activity
2 metricsNet insider buying (90D)
−$1.83M
Insider-sentiment score
29 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1793229
CUSIP
62548M209
13F (30d)
104 filings
98 filers
Visit website
Investor relations